Fair enough, I don't disagree with you. Except that I think it can and will jump to 60c (more or less) on approval as the current price isn't relative. It has so much bad news baked into it. And the price has swung 19-65c in the last year. Approval of Myring should bring minimum AU $70M revenue p/a. That is 10% share of US $1B market at 50% discount. Amneal have 10% share now and they have capacity issues. This $70M might only plug the gap to where we were, but the approval means so much more than that - it actually is a positive sign for E4 in that Myring will be the first Mithra manufactured product approved by FDA. So optimism around E4 will rise also.
MYX Price at posting:
38.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)